NCT01605201View on ClinicalTrials.gov

Tissue Engineered Nasal Cartilage for Regeneration of Articular Cartilage

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

August 29, 2012

Primary Completion Date

August 15, 2018

Study Completion Date

August 15, 2018

Conditions
Cartilage LesionDegenerative Lesion of Articular Cartilage of Knee
Interventions
BIOLOGICAL

Tissue engineered cartilage graft

Autologous nasal chondrocytes expanded in vitro and cultured in a collagen type I//III scaffold

Trial Locations (1)

4031

University Hospital Basel, Basel

All Listed Sponsors
collaborator

Deutsche Arthrose-Hilfe

OTHER

lead

University Hospital, Basel, Switzerland

OTHER

NCT01605201 - Tissue Engineered Nasal Cartilage for Regeneration of Articular Cartilage | Biotech Hunter | Biotech Hunter